Spherix Global Insights announces the launch of RealTime Dynamix, its new monthly service developed to keep clients on the pulse in highly dynamic specialty markets. RealTime Dynamix combines large scale primary market research with unparalleled market understanding to dig deeper and seek out the latest opinions and controversies that are impacting a specialty.
According to Dr Bonnie Bain, Senior Vice President of Commercial Operations at Spherix Global Insights, "RealTime Dynamix was created with biopharmaceutical decision-makers in mind and addresses a fundamental business challenge that they face each day – how to quickly turn the increasing amounts of data that they receive into real, actionable insights."
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status